Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The emerging role of Piezo1 in the musculoskeletal system and disease

Lei L., Wen Z., Cao M., Zhang H., Ling SK., Fu BS.

Narrative Review on Osteoarthritis, Tendon Injury, Disc Degeneration, published in Theranostics (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Theranostics (2024)
Reported sample size
—
Source database
Europe PMC
PMID
38994033
PMCID
PMC11234281
DOI
10.7150/thno.96959
Citations
47

Abstract (original English)

Piezo1, a mechanosensitive ion channel, has emerged as a key player in translating mechanical stimuli into biological signaling. Its involvement extends beyond physiological and pathological processes such as lymphatic vessel development, axon growth, vascular development, immunoregulation, and blood pressure regulation. The musculoskeletal system, responsible for structural support, movement, and homeostasis, has recently attracted attention regarding the significance of Piezo1. This review aims to provide a comprehensive summary of the current research on Piezo1 in the musculoskeletal system, highlighting its impact on bone formation, myogenesis, chondrogenesis, intervertebral disc homeostasis, tendon matrix cross-linking, and physical activity. Additionally, we explore the potential of targeting Piezo1 as a therapeutic approach for musculoskeletal disorders, including osteoporosis, muscle atrophy, intervertebral disc degeneration, and osteoarthritis.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Musculoskeletal SystemAnimalsHumansMusculoskeletal DiseasesIon ChannelsMechanotransduction, CellularOsteogenesisChondrogenesisMuscle Development

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research